吴轶喆,葛雷,沈雳,王齐兵,钱菊英,谢建,胡玺,葛均波

• 1:复旦大学附属中山医院心内科、上海市心血管病研究所
• 2:上海微特生物科技有限公司

摘要(Abstract)：

目的评价完全可降解聚-L-乳酸(PLLA)支架置入猪冠状动脉1月内早期支架弹性回缩。方法将XINSORB支架(XINSORB组)和EXCEL支架(EXCEL组)随机置入小型猪冠状动脉内,术后即刻、2 h、4 h和6 h行造影和血管内超声(IVUS)检查,术后4周复查IVUS。早期支架直径弹性回缩量定义为支架释放时球囊平均直径分别与支架术后即刻、2 h、4 h和6 h支架置入部位直径之差。早期支架直径弹性回缩百分数定义为支架直径弹性回缩量与球囊平均直径的比值,以百分数表示。早期支架面积弹性回缩量定义为术后即刻IVUS所测量的支架平均面积分别与术后2、4、6 h及术后4周时支架平均面积之差。早期支架面积弹性回缩百分数定义为支架平均面积弹性回缩量与术后即刻支架平均面积的比值,以百分数表示。结果 16头小型猪共置入32枚支架(XINSORB组16枚,EXCEL组16枚)。XINSORB组术后即刻、2 h、4 h和6 h支架直径弹性回缩量和百分数分别为(0.05±0.06)mm、(1.72±1.78)%,(0.10±0.07)mm、(3.34±2.43)%,(0.08±0.06)mm、(2.59±1.89)%和(0.09±0.05)mm、(2.99±1.69)%。EXCEL组不同时间点该两项指标分别为(0.02±0.06)mm、(0.58±2.02)%,(0.06±0.10)mm、(2.17±3.30)%,(0.07±0.08)mm、(2.19±2.72)%和(0.07±0.09)mm、(2.41±2.76)%。XINSORB组术后2 h、4 h、6 h和4周支架面积弹性回缩量和百分数分别为(0.05±0.13)mm2、(0.62±1.90)%,(0.04±0.35)mm2、(0.29±4.95)%,(0.22±0.46)mm2、(2.87±6.65)%和(0.31±0.27)mm2、(4.30±3.66)%。EXCEL组不同时间点该两项指标分别为(0.01±0.11)mm2、(0.04±1.59)%,(-0.03±0.36)mm2、(-0.44±5.34)%,(0.08±0.23)mm2、(1.02±3.41)%和(0.10±0.22)mm2、(1.44±3.35)%。不论是造影还是IVUS随访,两组支架均未发生明显弹性回缩,且弹性回缩程度相似。不同时间点IVUS均未发现支架贴壁不良征象。结论完全可降解XINSORB支架和EXCEL支架置入猪冠状动脉1月内,造影和IVUS随访未发现显著的支架弹性回缩,两组支架弹性回缩程度相似。两组支架均未见支架贴壁不良征象。

关键词(KeyWords)： 血管成形术,经腔,经皮冠状动脉;超声检查,介入性;冠状血管;猪

Abstract:

Keywords:

基金项目(Foundation): 上海市科委科技创新行动计划(11441900300);; 上海市科委纳米科技项目(11nm0504900);; 教育部高等学校博士学科点专项科研基金(20110071110053)

作者(Author): 吴轶喆,葛雷,沈雳,王齐兵,钱菊英,谢建,胡玺,葛均波

参考文献(References)：

• [1]Tamai H,Igaki K,Kyo E,et al.Initial and 6-month results ofbiodegradable poly-l-lactic acid coronary stents in humans.Circulation,2000,102:399-404.
• [2]Tsuji T,Tamai H,Igaki K,et al.Four-year follow-up of thebiodegradable stent(Igaki-Tamai Stent).Circ J,2004,68:135.
• [3]Nishio S,Kosuga K,Igaki K,et al.Long-Term(>10 Years)clinical outcomes of first-in-human biodegradable poly-l-lacticacid coronary stents:Igaki-Tamai stents.Circulation,2012,125:2343-2353.
• [4]Ormiston JA,Webster MW,Armstrong G.First-in-humanimplantation of a fully bioabsorbable drug-eluting stent:the BVSpoly-L-lactic acid everolimus-eluting coronary stent.CatheterCardiovasc Interv,2007,69:128-131.
• [5]Serruys PW,Ormiston JA,Onuma Y,et al.A bioabsorbableeverolimus-eluting coronary stent system(ABSORB):2-yearoutcomes and results from multiple imaging methods.Lancet,2009,373:897-910.
• [6]Serruys PW,Onuma Y,Dudek D,et al.Evaluation of thesecond generation of a bioresorbable everolimus-eluting vascularscaffold for the treatment of de novo coronary artery stenosis:12-month clinical and imaging outcomes.J Am Coll Cardiol,2011,58:1578-1588.
• [7]Chen C,Chueh J,Tseng H,et al.Preparation andcharacterization of biodegradable PLA polymeric blends.Biomaterials,2003,24:1167-1173.
• [8]Onuma Y,Serruys PW.Bioresorbable scaffold:the advent of anew era in percutaneous coronary and peripheralrevascularizationCirculation,2011,123:779-797.
• [9]Stack RS,Califf RM,Phillips HR,et al.Interventional cardiaccatheterization at Duke Medical Center.Am J Cardiol,1988,62:3F-24F.
• [10]Venkatraman S,Poh TL,Vinalia T,et al.Collapse pressures ofbiodegradable stents.Biomaterials,2003,24:2105-2111.
• [11]Rieu R,Barragan P,Masson C,et al.Radial force of coronarystents:a comparative analysis.Catheter Cardiovasc Interv,1999,46:380-391.
• [12]Zilberman M,Nelson KD,Eberhart RC.Mechanical propertiesand in vitro degradation of bioresorbable fibers and expandablefiber-based stents.J Biomed Mater Res B Appl Biomater,2005,74:792-799.
• [13]Tanimoto S,Serruys PW,Thuesen L,et al.Comparison of invivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromiumcoronary stent:insights from the ABSORB and SPIRIT trials.Catheter Cardiovasc Interv,2007,70:515-523.
• [14]Onuma Y,Serruys PW,Gomez J,et al.Comparison of in vivoacute stent recoil between the bioresorbable everolimus-elutingcoronary scaffolds(revision 1.0 and 1.1)and the metalliceverolimus-eluting stent.Catheter Cardiovasc Interv,2011,78:3-12.
• [15]陈爱宝,罗七一.可降解支架材料热学、机械性能及与受体的生物相容性.中国组织工程研究与临床康复,2010,14:5475-5478.
• [16]Briguori C,Sarais C,Pagnotta P,et al.In-stent restenosis insmall coronary arteries:Impact of strut thickness.J Am CollCardiol,2002,40:403-409.
• [17]Pache J,Kastrati A,Mehilli J,et al.Intracoronary stenting andangiographic results:Strut thickness effect on restenosis outcome(ISAR-STEREO-2)trial.J Am Coll Cardiol,2003,41:1283-1288.